Congress has authorized funding aimed at combatting HIV/AIDS on a global scale, recognizing the significant impact of U.S. efforts in saving millions of lives.
However, the Trump administration has been notably slow in disbursing these funds, leading to concerns about the continuity and effectiveness of ongoing programs.
The unpredictability of funding not only affects immediate response capabilities but also undermines long-term planning and infrastructure development in global health initiatives.